Inhibitor name | Representative structure(s) | Target | Mode of action | Reference |
---|---|---|---|---|
BBo | 3-chlorophenylboronic acid, 4-biphenylboronic acid | YUCCA | Competitive inhibitor | [50] |
PPBo | 4-phenoxyphenyl-boronic acid | YUCCA | Competitive inhibitor | [50] |
Ponalrestat | 2-(3-(4-Bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid | YUCCA | Substrate antagonist | [51] |
Yucasin | 5-(4-chlorophenyl)-4H-1,2,4-triazole-3-thione | YUCCA | Competitive inhibitor | [52] |
Yucasin DF (YDF) | 5-[2,6-difluorophenyl]-2,4-dihydro-[1,2,4]triazole-3-thione | YUCCA | Competitive inhibitor | [53] |
Pyruvamines (PVM) “Type I compounds” | PVM1169; L-alpha-(aminooxy)-3-(naphthalen-2-yl)propanoic acid | TAA1 | Competitive inhibitor | [20] |
Pyruvamines (PVM) “Type II compounds” (Derivatives of Type I compounds) | PVM2153; Benzene propanoic acid, 3,4-dichloro-α-[(1,3-dihydro-1,3-dioxo- 2H-isoindol-2-yl)oxy]-, methyl ester | TAA1 | Competitive inhibitor | [20] |
L-Kynurenine (Kyn) | (2S)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid | TAA1 | Alternative substrate/ Competitive inhibitor | [54] |
AVG | Aminoethoxyvinyl-glycine | TAA1 | Slow-binding inhibition | [55] |
AOPP | L-aminooxyphenyl-propionic acid | TAA1 | Competitive inhibitor | [55] |
AOA | Amino-oxyacetic acid | TAA1 | [55] | |
AOIBA | 2-amino-oxyisobutyric acid | TAA1 | [55] | |
Indoleacrylic acid | trans-indole-3-acrylic acid | Trp synthase β and α | Allosteric inhibitor | |
(1-Fluorovinyl)glycine | α-(1′-fluoro)vinyl glycine | Trp synthase β | PLP-enzyme mechanism-based inhibitor | [58] |
Arylsulfide phosphonates | [4-[(2-aminophenyl) sulfanyl]butyl] phosphonic acid | Trp synthase α | Transition state analog | |
Indoline-5-sulfonamides | 1-(2-Fluorobenzoyl)-N-methyl-5-indoline sulfonamide N-Methyl-1-[(5-methyl-2-thienyl)carbonyl]-5-indolinesulfonamide | Trp synthase inter- subunit interface | Allosteric inhibitor | [61] |
Sulfolane and indole-5-sulfonamide | GSK1, (3R,4R)-4-[4-(2-chlorophenyl)piperazin-1-yl]-1,1-dioxothiolan- 3-ol); GSK2, (1-[2-fluorobenzoyl]-N-methyl-2,- 3-dihydro-1H-indole-5-sulfonamide) | Trp synthase inter- subunit interface | Allosteric inhibitor | [62] |
Aryl sulfonamides | [F9]; N-(4’-Trifluoromethoxy benzenesulfonyl)-2-aminoethyl Phosphate | Trp synthase β | α-Site allosteric ligand | [63] |
Benzamide | N-(4-Carbamoyl benzyl)-5-(3-chloro phenyl)-1,2-oxazole-3-carboxamide | Trp synthase α | α-Site ligand | [64] |